News

Shoppers Drug Mart and Avicanna Execute Definitive Asset Purchase Agreement for Avicanna’s Acquisition of the Medical Cannabis by Shoppers Business

Shoppers Drug Mart and Avicanna Execute Definitive Asset Purchase Agreement for Avicanna’s Acquisition of the Medical Cannabis by Shoppers Business…

2 years ago

StateHouse to Report First Quarter 2023 Financial Results on May 31st, 2023

SAN DIEGO and TORONTO, May 29, 2023 (GLOBE NEWSWIRE) -- StateHouse Holdings Inc. (“StateHouse” or the “Company”) (CSE: STHZ) (OTCQX:…

2 years ago

Mithra Appoints Experienced Life Sciences Executive Christian Homsy* as Chairman

Inge Beernaert appointed President of the Compensation and Nomination CommitteeJacques Galloy appointed President of the Audit CommitteeLiege, Belgium, 29 May…

2 years ago

BioSenic provides update regarding current license agreement with Phebra

INSIDE INFORMATION Maintenance of the license is now subject to the launch of the OATO Phase III before May 2024…

2 years ago

PwC and Claritas HealthTech Enter into Strategic Relationship for the Deployment of Claritas’ Medical Imaging Platforms

SINGAPORE and LONDON, May 28, 2023 (GLOBE NEWSWIRE) -- Claritas HealthTech and PwC today announced that they will collaborate on…

2 years ago

Iovance Biotherapeutics Announces U.S. Food and Drug Administration Acceptance of the Biologics License Application of Lifileucel for the Treatment of Advanced Melanoma

Priority Review Granted withPrescription Drug User Fee Act (PDUFA) Action Date of November 25, 2023 First Potential Approval of an…

2 years ago

Molecular Templates to Present on Phase I Dose Escalation Study of MT-6402 at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

AUSTIN, Texas, May 26, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company…

2 years ago

Biodexa Pharmaceuticals PLC Announces Closing of $3.32 Million Registered Direct Offering

26 May 2023 Biodexa Pharmaceuticals PLC Announces Closing of $3.32 Million Registered Direct Offering               Biodexa Pharmaceuticals PLC (“Biodexa” or…

2 years ago

Lexicon Announces FDA Approval of INPEFA™ (sotagliflozin) for Treatment of Heart Failure

INPEFA granted broadacross full range of left ventricular ejection fraction, including HFpEF and HFrEF, and for patients with…

2 years ago

electroCore, Inc. Announces Departure of JP Errico from the Board of Directors

ROCKAWAY, N.J., May 26, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced…

2 years ago